The global anti-counterfeit packaging market size was estimated at USD 177.92 billion in 2024 and is projected to reach USD 345.93 billion by 2030, registering a CAGR of 11.7% from 2025 to 2030. The increasing demand for brand protection solutions, particularly for pharmaceutical products, is a significant driver of this growth.

 

Additionally, the ease of product monitoring throughout the supply chain is anticipated to further propel market growth over the next seven years. Technological advancements that enhance the capabilities of anti-counterfeit solutions are also expected to contribute to market expansion.

 

A primary driver of the market is the growing global concern regarding product counterfeiting, especially in pharmaceuticals, luxury goods, and consumer electronics. For example, according to data from US Customs and Border Protection, over USD 2.0 billion worth of goods and more than USD 20.0 million worth of counterfeit drugs were seized at the U.S. border in 2022. Consequently, the increasing investments by drug manufacturers and the U.S. government to address counterfeiting issues are likely to stimulate industry growth throughout the forecast period.

 

Key Market Trends & Insights

  • North America dominated the global market, accounting for the largest revenue share of over 43.0% in 2024. This dominance is attributed to a robust regulatory framework and stringent enforcement measures. The FDA's Drug Supply Chain Security Act (DSCSA) and the Food Safety Modernization Act (FSMA) have mandated advanced tracking and authentication systems for pharmaceuticals and food products.
  • By technology, the track & trace segment led the overall market with a revenue share of over 49.0% in 2024 and is expected to exhibit strong growth with a CAGR of 12.2% during the forecast period. These technologies facilitate real-time product monitoring throughout the supply chain, utilizing serialization, barcodes, RFID tags, or QR codes that provide unique identifiers for each product.
  • By application, the pharmaceutical segment captured the largest revenue share of over 27.0% in 2024 and is anticipated to experience significant growth with a CAGR of 12.7% over the forecast period. Anti-counterfeit packaging in the pharmaceutical sector is crucial for ensuring the authenticity of medicines, helping to prevent the circulation of counterfeit drugs that could endanger patients.

 

Order a free sample PDF of the Anti-counterfeit Packaging Market Intelligence Study, published by Grand View Research.

 

Market Size & Forecast

  • 2024 Market Size: USD 177.92 Billion
  • 2030 Projected Market Size: USD 345.93 Billion
  • CAGR (2025-2030): 11.7%
  • North America: Largest market in 2024

 

Key Companies & Market Share Insights

The market is characterized by fragmentation, with numerous small manufacturers entering with innovative production technologies. Competition among companies is largely driven by the technology offered and the level of innovation implemented. Firms are investing heavily in mergers & acquisitions, R&D, and innovation to gain a competitive edge.

 

Key Players

  • 3M
  • AVERY DENNISON CORPORATION
  • CCL Industries
  • DuPont
  • Zebra Technologies Corp.
  • ITL Group
  • SML Group
  • SATO Holdings Corporation
  • SICPA HOLDING SA
  • Systech International
  • Applied DNA Sciences
  • AlpVision SA
  • Authentix
  • Atlantic Zeiser GmbH

 

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

 

Conclusion

The anti-counterfeit packaging market is poised for substantial growth driven by technological advancements, regulatory requirements, and a heightened focus on brand protection. With significant investments in innovation and a proactive approach to combating counterfeiting, the industry is likely to evolve rapidly, addressing the critical challenges posed by product fraud across various sectors.